Factor | Categories | Adjusted PRR | p-value |
---|---|---|---|
Socio-demographic | |||
 Age groups | 18–24 | 1 | 1 |
25–34 | 1.10 (0.88–1.34) | 0.41 | |
35–44 | 0.99 (0.75–1.29) | 0.95 | |
45–54 | 1.18 (0.93–1.49) | 0.17 | |
≥55 | 1.17 (0.79–1.76) | 0.43 | |
 Gender | Male | 1 | 1 |
Female | 0.94 (0.82–1.06) | 0.31 | |
 Education status | None | 1 | 1 |
Primary | 0.96 (0.83–1.10) | 0.54 | |
Secondary | 1.00 (0.88–1.15) | 0.95 | |
Post-secondary | 1.05 (0.89–1.25) | 0.52 | |
Clinical factors | |||
 Current Diagnosis | Hep B | 1 | 1 |
Hep B & C | 0.52 (0.13–2.08) | 0.36 | |
Hep C | 1.16 (1.07–1.31) | 0.02 | |
Others | 1.04 (0.92–1.17) | 0.52 | |
 Time since diagnosis | <  6 months | 1 | 1 |
6–12 months | 0.96 (0.84–1.10) | 0.52 | |
13–24 months | 0.69 (0.49–0.98) | 0.03 | |
>  24 months | 0.77 (0.59–0.98) | 0.05 | |
 On conventional treatment | No | 1 | 1 |
Yes | 0.99 (0.87–1.15) | 0.98 | |
Safety profile | |||
 Safe to use both | No | 1 | 1 |
Yes | 1.23 (1.05–1.43) | 0.008 | |
Not sure | 1.32 (1.10–1.59) | 0.003 |